The replicative CMG helicase: the ideal target for cancer therapy

by W. Henderson, K. Nyman, M. Stoney, S. I. Borysov
Published 2020-12-01

Is this study feasible? Facilitating management of pragmatic trial planning milestones under a phased award funding mechanism

by Paula Darby Lipman, Leanora Dluzak, Catherine M. Stoney
Published 2019-05-01

Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains

by Paula Darby Lipman, Kirsty Loudon, Leanora Dluzak, Rachael Moloney, Donna Messner, Catherine M. Stoney
Published 2017-11-01